T cell cytokine pattern in the joints of patients with lyme arthritis and its regulation by cytokines and anticytokines

Arthritis and Rheumatism

Volumn 40, Issue 1, 1997, Pages 69-79

  Yin, Zhinan ^a,b   Braun, Jürgen ^a   Neure, Lucia ^a,b   Wu, Peihua ^b   Eggens, Ulrich ^a   Krause, Andreas ^c   Kamradt, Thomas ^b,c   Sieper, Joachim ^a,b,d  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c HUMBOLDT UNIVERSITY   (Germany)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELPER CELL; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LYME DISEASE; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADOLESCENT; ADULT; CELLS, CULTURED; CHILD; CYTOKINES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-10; JOINTS; LEUKOCYTES, MONONUCLEAR; LYME DISEASE; MALE; MIDDLE AGED; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TH1 CELLS; TH2 CELLS;

EID: 0031037620     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.1780400111     Document Type: Article

References (43)

1. Harbour AG, Fish D: The biological and social phenomenon of Lyme disease. Science 260:1610-1616, 1993
2. Steere AC: Lyme disease. N Engl J Med 321:586-596, 1989
3. Bradley JF, Johnson RC, Goodman JL: The persistence of spirochetal nucleic acids in active Lyme arthritis. Ann Intern Med 120:487-489, 1994
4. Nocton JJ, Dressier F, Rutledge BJ, Rys PN, Persing DH, Steere AC: Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid from patients with Lyme arthritis. N Engl J Med 330:229-234, 1994
5. Burmester GR, Daser A, Kamradt T, Krause A, Mitchison NA, Sieper J, Wolf N: Immunology of reactive arthritides. Annu Rev Immunol 13:229-250, 1995
6. Romagnani S: Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257, 1994
7. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241-251, 1994
8. Del Prete G, de Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S: Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-360, 1993
9. Debets R, Savelkoul HFJ: Cytokine antagonists and their potential therapeutic use. Immunol Today 15:455-458, 1994
10. Röcken M, Racke M, Shevach EM: IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17:225-231, 1996
11. Farrar MA, Schreiber RD: The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611, 1993
12. Steinman L: A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci U S A 93:2253-2256, 1996
13. Matyniak JE, Reiner SL: T helper phenotype and genetic susceptibility in experimental Lyme disease. J Exp Med 181:1251-1254, 1995
14. Keane Myers A, Nickell SP: Role of IL-4 and IFN-gamma in modulation of immunity to Borrelia burgdorferi in mice. J Immunol 155:2020-2028, 1995
15. Keane Myers A, Maliszewski CR, Finkelman FD, Nickell SP: Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J Immunol 156:2488-2494, 1996
16. Schoenberg A, Camey C, Kahl O, Wilske B, Preac Mursic V, Hovind Hougen K: First isolation of Borrelia burgdorferi, the agent of Lyme borreliosis, from Ixodes ricinus (Acari: Ixodidae) in Berlin (West). Zentralb1 Bakteriol Mikrobiol Hyg A 268:487-494, 1988
17. Sieper J, Braun J, Brandt J, Miksits K, Heesemann J, Laitko S, Sorensen H, Distler A, Kingsley G: Pathogenetic role of Chlamydia, Yersinia and Borrelia in undifferentiated oligoarthritis. J Rheumatol 19:1236-1242, 1992
18. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387-1398, 1992
19. Simon AK, Seipelt E, Wu P, Wenzel B, Braun J, Sieper J: Analysis of cytokine profiles in synovial T cell clones from chlamydial reactive arthritis patients: predominance of the Th1 subset. Clin Exp Immunol 94:122-126, 1993
20. Melby PC, Darnell BJ, Tryon W: Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods 159:235-244, 1993
21. Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J: Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38:499-505, 1995
22. Ulfgren AK, Lindblad S, Klareskog L, Andersson J, Andersson U: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 54:654-661, 1995
23. Anguita J, Persing DH, Rincon M, Barthold SW, Fikrig E: Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J Clin Invest 97:1028-1034, 1996
24. Yssel H, Shanafelt MC, Soderberg C, Schneider PV, Anzola J, Peltz G: Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis. J Exp Med 174:593-601, 1991
25. Yang L, Ma Y, Schoenfeld R, Griffiths M, Eichwald E, Araneo B, Weis JJ: Evidence for B-lymphocyte mitogen activity in Borrelia burgdorferi-infected mice. Infect Immun 60:3033-3041, 1992
26. Kamradt T, Infante-Duarte C: Borrelia-induced regulation of T helper phenotype in T-cell-receptor transgenic mice (abstract). Arthritis Rheum 38 (suppl 9):S344, 1995
27. Lengl Janssen B, Strauss AF, Steere AC, Kamradt T: The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis. J Exp Med 180:2069-2078, 1994
28. Kamradt T, Krause A, Burmester GR: A role for T cells in the pathogenesis of treatment-resistant Lyme arthritis. Mol Med 1:486-490, 1995
29. Chen Y, Kuchroo VK, Inobe M, Hafler DA, Meiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 265:1237-1240, 1994
30. Bessis N, Boissier M-C, Caput D, Fradelizi D, Fournier C: IL-4 or IL-13 transfected xenogenic fibroblasts in the treatment of collagen induced arthritis in mice (abstract). Clin Rheumatol 14:261, 1995
31. Rapoport MJ, Jaramillo A, Zipris D, Lazarus AH, Serreze DV, Leiter EH, Cyopick P, Danska JS, Delovich TL: Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese mice. J Exp Med 178:97-99, 1993
32. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11:165-190, 1993
33. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A: IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822, 1991
34. Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A: IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J Immunol 146:3444-3451, 1991
35. Katsikis PD, Chu CQ, Brennan FM, Maini RN, Feldmann M: Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J Exp Med 179:1517-1527, 1994
36. Miossec P: Interleukin-4 and interleukin-10 as antagonists of interferon-gamma. J Interferon Res 14:285, 1994
37. Miossec P, Briolay J, Dechanet J, Wijdenes J, Martinez-Valdez H, Banchereau J: Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. Arthritis Rheum 35:874-883, 1992
38. Trinchieri G: Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995
39. Vassalli P: The pathophysiology of tumor necrosis factor. Annu Rev Immunol 10:411-452, 1992
40. Williams RO, Feldmann M, Maini RN: Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 89:9784-9788, 1992
41. Elliott MJ, Maini RN, Feldmann M, Long Fox A, Charles P, Bijl H, Woody JN: Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis. Lancet 344:1125-1127, 1994
42. Defosse DL, Johnson RC: In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect Immun 60: 1109-1113, 1992
43. Simon AK, Seipelt E, Sieper J: Divergent T-cell cytokine patterns in inflammatory arthritis. Proc Natl Acad Sci U S A 91:8562-8566, 1994